Latest Business Strategy News

MFF Capital Investments appoints Gerald Stack as CEO and Managing Director, signaling a strategic evolution with a proposed dividend increase to 10 cents per share.

McPherson’s Limited has unveiled a sweeping two-year transformation, streamlining its brand portfolio and adopting a scalable third-party logistics model to drive growth and improve financial stability.

K2 Asset Management Holdings Ltd marked a pivotal year with 17% revenue growth and a return to profitability, declaring a fully franked dividend and outlining ambitious growth plans across its core business pillars.

Altech Batteries confirms the strategic importance of its AMPower Agreement, enabling immediate sales and cash flow, while detailing a recent $6 million capital raising and addressing trading compliance issues.

Uscom Limited reported a 27% drop in cash reserves for Q1 2025, driven by declining revenue and rising costs, while preparing to sell its main business unit to stabilize finances.

Novonix Limited has achieved its first mass production of industrial-grade synthetic graphite and secured significant funding, advancing its position in North America's battery materials supply chain.

Restaurant Brands New Zealand’s Independent Directors unanimously recommend shareholders accept Finaccess Restauración’s NZ$5.05 per share takeover offer, citing significant premium and risk mitigation despite the offer being below assessed valuation.

Freehill Mining Limited is expanding its aggregates product range and upgrading its processing capabilities at the Islon site to meet rising demand from the local cement industry in Chile.

TZ Limited appoints Antonino Schiavello as Non-Executive Director and partners with his Nura Space venture to accelerate workplace technology solutions, while securing a $750,000 credit extension to support product delivery.

333D Limited has responded to ASX queries, clarifying that its Bitcoin Treasury Management Policy approval is not price sensitive, while disclosing a $370,500 Bitcoin acquisition funded partly by R&D tax incentives.

Next Science Limited reported a 7% revenue decline and a 20% reduction in net loss for H1 2025, alongside a major $50 million asset sale agreement with OSARTIS GmbH. The transaction, approved by shareholders, signals a strategic pivot for the biofilm-focused medical device company.

Shriro Holdings reported a 5.5% beat on EBITDA guidance despite a 13.6% revenue decline driven by strategic shifts in its importer model and distributor consolidation. The company signals optimism for FY26 with new product launches and a capital-light growth strategy.